Cargando…
Valproic acid-induced hyperammonemic encephalopathy: a clinical case
INTRODUCTION: Valproic acid is a psychotropic drug used for several years, due to its properties as a mood stabilizer, being considered as first-line treatment for bipolar disorder. In addition to its teratogenic potential, which prevents its recommendation for the treatment of bipolar disorder in w...
Autores principales: | Felizardo, M., Freitas, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568048/ http://dx.doi.org/10.1192/j.eurpsy.2022.1881 |
Ejemplares similares
-
Hyperammonemic Encephalopathy: valproic acid-induced adverse reaction
por: Gómez, E., et al.
Publicado: (2023) -
A Case of Valproic-Acid Induced Hyperammonemic Encephalopathy
por: Iqbal, Kinza, et al.
Publicado: (2021) -
Valproic Acid-induced Hyperammonemic Encephalopathy Promoted by Levetiracetam
por: Roh, Sook Young, et al.
Publicado: (2014) -
Hyperammonemic Encephalopathy due to Valproic Acid and Topiramate Interaction
por: Twilla, Jennifer D., et al.
Publicado: (2014) -
Valproic acid-induced hyperammonemic encephalopathy (VIHE) in a patient with Bipolar disorder: A case report and literature review
por: Isidahome, E., et al.
Publicado: (2022)